Innovation of Nanotheranostics for Precise Diagnostics and Therapeutics of Diseases
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 6991
Interests: polymer chemistry; molecular imaging probes; nanomedicines; prodrugs; aggregation-induced emission; fluorescence imaging; photoacoustic imaging; microscopy; wide-field imaging; two photon imaging; second harmonic imaging
Special Issues, Collections and Topics in MDPI journals
Nowadays, the development of nanotheranostics, which integrates diagnostics and therapeutics into a single nanoplatform, has been expedited in many preclinical and clinical scenarios. Nanotheranostics development depends on the innovation of nanomaterials and corresponding formulation technology. In this Special Issue, we aim to focus on the state-of-the-art nanomaterials for diagnostics (e.g., magnetic resonance imaging, fluorescence imaging, photoacoustic imaging, ultrasound imaging, computerized tomography, and positron emission tomography) and therapeutics (e.g., chemotherapy, immunotherapy, radiotherapy, surgery, sonodynamic therapy, chemodynamic therapy, and photodynamic therapy) for different life-threatening diseases, such as cancer, cardiovascular diseases, inflammation, neurodegenerative diseases, and bone diseases. In addition, we plan to present nanotechnologies for the fabrication of theranostic medicine, which include microfluidics, nanoprecipitation, emulsion and solvent-evaporation, surface modification, exosome production, and biomimetic cellular membrane coating. Potential topics include, but are not limited to: biomimetic nanomedicines, image-guided drug delivery, theranostic nanomedicines for the treatment of bacterial infections, nanomaterials for synergistic imaging and therapy, nanotechnologies for theranostic nanomedicine production, nanomaterials for multimodal imaging, and nanomaterials for combinatory therapeutics and targeted therapy.
Dr. Bing Guo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- active targeting
- biomimetic nanomedicines